Lyell Immunopharma (LYEL) EBITDA Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 530.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -932.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 7,003.00
10 Lyell Immunopharma 379.11 Mn 379.11 Mn - -112.29 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -112.29 Mn
Dec 31, 2025 -234.47 Mn
Sep 30, 2025 213.86 Mn
Jun 30, 2025 -53.47 Mn
Mar 31, 2025 -73.43 Mn
Dec 31, 2024 -174.61 Mn
Sep 30, 2024 -12.59 Mn
Jun 30, 2024 -34.99 Mn
Mar 31, 2024 -203.03 Mn
Dec 31, 2023 -39.71 Mn
Sep 30, 2023 -19.52 Mn
Jun 30, 2023 -22.78 Mn